非甾体抗炎药在信号通路和miRNA调控通路中的效应建模

基于COX通路和信号通路的NSAID效应模型数据集,整合基因表达与调控数据,用于预测个体肿瘤药物反应及miRNA生物标志物发现,助力个性化医疗。

NIAID Data Ecosystem
浏览 11
文本、表格non-steroidalanti-inflammatorypathwaysmirna-regulation
Modeling of Non-Steroidal Anti-Inflammatory Drug Effect within Signaling Pathways and miRNA-Regulation Pathways

基本信息

模态
文本、表格
大小
0.001084313 GB
许可
CC BY 4.0
创建/更新时间
2026-10-07
版本
v1

资源简介

非甾体抗炎药在信号通路和miRNA调控通路中的效应建模

【一句话概览】

本数据集是 figshare 公开的结构化表格数据集,收录 4 个文件、合计 1.08 MB,主题涵盖 non-steroidal、anti-inflammatory、pathways、mirna-regulation,可用于统计建模、特征工程与队列分析,CC BY 4.0 许可开放获取。

【数据集背景】

本数据集源站标题为《Modeling of Non-Steroidal Anti-Inflammatory Drug Effect within Signaling Pathways and miRNA-Regulation Pathways》。配套论文《Modeling of Non-Steroidal Anti-Inflammatory Drug Effect within Signaling Pathways and miRNA-Regulation Pathways》发表于 PLoS ONE(2013),DOI:10.1371/journal.pone.0072477。源站首次发布:2013-08-14。

【数据内容】

源站原始描述:To date, it is widely recognized that Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) can exert considerable anti-tumor effects regarding many types of cancers. The prolonged use of NSAIDs is highly associated with diverse side effects. Therefore, tailoring down the NSAID application onto individual patients has become a necessary and relevant step towards personalized medicine. This study conducts the systemsbiological approach to construct a molecular model (NSAID model) containing a cyclooxyge…

文件 Information_S3.txt 为文本内容,开头为:Supplementary Information 3: The ID of three tumor cell lines: The applied 60 tumor cell lines from three tumor types (breast, colon, and lung) are provided …

【数据结构与技术规格】

文件数 4 个,合计 1.08 MB。Information_S1.doc:application/msword,1.00 MB。Information_S2.xls:application/vnd.ms-excel,30.21 KB。Information_S3.txt:text/plain,3.90 KB。数据集 DOI:10.1371/journal.pone.0072477。

【主题与分类】

源站学科分类:Biological Sciences。主题标签:non-steroidal、anti-inflammatory、pathways、mirna-regulation。

【适用方向】

结构化表格数据可直接用于统计建模、特征工程与队列分析。

【获取与许可】

源站页面:https://plos.figshare.com/articles/dataset/_Modeling_of_Non_Steroidal_Anti_Inflammatory_Drug_Effect_within_Signaling_Pathways_and_miRNA_Regulation_Pathways_/772670

使用许可:CC BY 4.0(https://creativecommons.org/licenses/by/4.0/)。

规范引用:Li, Jian; R. Mansmann, Ulrich (2016). Modeling of Non-Steroidal Anti-Inflammatory Drug Effect within Signaling Pathways and miRNA-Regulation Pathways. PLOS ONE. Dataset

【使用注意】

· 源站最后修改于 2023-05-30,引用时请注意版本时效。

官方服务

专家保障全链路合规授权与标注交付

陕川双基地 × 超十家三甲医院直连

从合规授权、采集治理、专业标注到数据集交付,我们提供全链路闭环服务,让高质量临床数据即拿即用。

⚡️ 需要原始数据或标注支持?联系我们获取定制方案。

帮我联系

下载信息

注册下载

需要注册 Kaggle 账号并登录后下载,适合需要跟踪下载记录和使用 API 的用户。

暂未开放

公开下载

无需注册即可直接获取公开样本或文档,适合快速预览和评估数据集质量。

免登录

有偿下载

公开数据集受托下载与技术交付服务。

提供高速下载与技术交付服务(收技术服务费,非数据销售)

暂未开放

当前数据集主要来源为 Kaggle 公开托管,完整影像包建议通过原始链接或 Kaggle API 获取。

使用方式

数据集获取(Figshare)

命令行下载

curl -L -o "Information_S1.doc" "https://ndownloader.figshare.com/files/1169935"
curl -L -o "Information_S2.xls" "https://ndownloader.figshare.com/files/1169940"
curl -L -o "Information_S3.txt" "https://ndownloader.figshare.com/files/1169941"
curl -L -o "Information_S4.csv" "https://ndownloader.figshare.com/files/1169942"

文件清单

  • Information_S1.doc(1.00 MB)
  • Information_S2.xls(30.21 KB)
  • Information_S3.txt(3.90 KB)
  • Information_S4.csv(46.18 KB)

文件总体积 1.08 MB(源站 API 实测)。

数据加载示例(图像类)

from PIL import Image
import glob, os

files = (glob.glob(os.path.join(path, "**", "*.png"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.jpg"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.tif"), recursive=True))
print("图像文件数:", len(files))
img = Image.open(files[0]); print("尺寸/模式:", img.size, img.mode)

# torchvision Dataset 方式:
# from torchvision import datasets
# ds = datasets.ImageFolder(path)  # 要求 子目录=类别

目录组织与标注格式以源站说明和下载后实际文件为准。

数据说明

To date, it is widely recognized that Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) can exert considerable anti-tumor effects regarding many types of cancers. The prolonged use of NSAIDs is highly associated with diverse side effects. Therefore, tailoring down the NSAID application onto individual patients has become a necessary and relevant step towards personalized medicine. This study conducts the systemsbiological approach to construct a molecular model (NSAID model) containing a cyclooxygenase (COX)-pathway and its related signaling pathways. Four cancer hallmarks are integrated into the model to reflect different developmental aspects of tumorigenesis. In addition, a Flux-Comparative-Analysis (FCA) based on Petri net is developed to transfer the dynamic properties (including drug responsiveness) of individual cellular system into the model. The gene expression profiles of different tumor-types with available drug-response information are applied to validate the predictive ability of the NSAID model. Moreover, two therapeutic developmental strategies, synthetic lethality and microRNA (miRNA) biomarker discovery, are investigated based on the COX-pathway. In conclusion, the result of this study demonstrates that the NSAID model involving gene expression, gene regulation, signal transduction, protein interaction and other cellular processes, is able to predict the individual cellular responses for different therapeutic interventions (such as NS-398 and COX-2 specific siRNA inhibition). This strongly indicates that this type of model is able to reflect the physiological, developmental and pathological processes of an individual. The approach of miRNA biomarker discovery is demonstrated for identifying miRNAs with oncogenic and tumor suppressive functions for individual cell lines of breast-, colon- and lung-tumor. The achieved results are in line with different independent studies that investigated miRNA biomarker related to diagnostics of cancer treatments, therefore it might shed light on the development of biomarker discovery at individual level. Particular results of this study might contribute to step further towards personalized medicine with the system

许可

CC BY 4.0

引用

学术使用请引用 DOI 10.1371/journal.pone.0072477(source: https://plos.figshare.com/articles/dataset/_Modeling_of_Non_Steroidal_Anti_Inflammatory_Drug_Effect_within_Signaling_Pathways_and_miRNA_Regulation_Pathways_/772670)。

数据缺失?

依托陕西、四川两大基地,我们与超过十家三甲医院建立直接合作关系,覆盖合规授权、采集治理、专业标注、数据交付的全流程,为AI医疗团队提供即拿即用的高质量临床数据。

⚡️ 需要数据支持或标注服务?立即联系我们获取专业方案。

获取专属数据定制方案